Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00644
|
|||||
| Drug Name |
Disopyramide
|
|||||
| Synonyms |
4-(diisopropylamino)-2-phenyl-2-pyridin-2-ylbutanamide; 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide; Alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide; Alpha-Diisopropylaminoethyl-alpha-phenylpyridine-2-acetamide; Alpha-[2-[Bis(1-methylethyl)amino]ethyl]-alpha-phenyl-2-pyridine acetamide; D 7644; Dicorantil; Disopiramida; Disopiramida [INN-Spanish]; Disopyramide (JP15/USAN/INN); Disopyramide Free Base; Disopyramide [USAN:BAN:INN:JAN]; Disopyramidum; Disopyramidum [INN-Latin]; Gamma-Diisopropylamino-alpha-phenyl-alpha-(2-pyridyl)butyramide; H 3292; Isorythm; Lispine; Norpace (TN); Ritmodan; Rythmodan; Rythmodan (TN); Rythmodan P; Rythmodan P (TN); Rythmodan-La; SC 7031; SC-7031; Searle 703; Xi-Disopyramide
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Ventricular arrhythmias [ICD11: BC71] | Approved | [1] | |||
| Therapeutic Class |
Antiarrhythmic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H29N3O
|
|||||
| Canonical SMILES |
CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
|
|||||
| InChI |
InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)
|
|||||
| InChIKey |
UVTNFZQICZKOEM-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 3737-09-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 339.5 | Topological Polar Surface Area | 59.2 | ||
| Heavy Atom Count | 25 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321641
, 10520689
, 11335664
, 11360903
, 11363902
, 11366464
, 11369026
, 11371248
, 11374266
, 11377188
, 11461875
, 11466294
, 11467414
, 11484981
, 11486067
, 11488849
, 11490220
, 11492339
, 11494822
, 14777930
, 17404965
, 24278384
, 29222256
, 46508226
, 47440202
, 47736425
, 47810710
, 47959691
, 47959692
, 47959693
, 48035065
, 48110414
, 48184952
, 49698859
, 50068860
, 50106174
, 50106175
, 50106176
, 50899557
, 53777508
, 53786857
, 56394974
, 57321616
, 7343341
, 7847369
, 7979107
, 8151982
, 85085689
, 85148360
, 9179
|
|||||
| ChEBI ID |
ChEBI:4657
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Disopyramide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2. J Med Chem. 2013 Sep 26;56(18):7232-42. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.